Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ANALYST INTERVIEW: BIOTECHNOLOGY: INDUSTRY OVERVIEW: CAROLYN PRATT - NEEDHAM & CO.


(PAP900) BIOTECHNOLOGY: INDUSTRY OVERVIEW: CAROLYN PRATT PRATT Point Refuted A Thousand Times (online debates)  - NEEDHAM & CO. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 6/2/02. Tickers featured: ABGX, ALKS ALKS Alkermes, Inc. (stock symbol) , CRXA, DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
, EMIS, IDPH, IMCL, INHL, JNJ, LEXG, MLNM, TLRK, VPHM. Complete text approximately 3000 words. Document # PAP900.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:ANALYST INTERVIEW: BIOTECHNOLOGY: INDUSTRY OVERVIEW: CAROLYN PRATT - NEEDHAM & CO.(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:107
Previous Article:ANALYST INTERVIEW: EMERGING BIOTECHNOLOGY COMPANIES:MARK MONANE - NEEDHAM & CO.
Next Article:CEO INTERVIEW: STEVEN BERNITZ - ORGANOGENESIS INC (ORG).
Topics:



Related Articles
ANALYST INTERVIEW: THE BIOTECHNOLOGY REVOLUTION: AN OVERVIEW: CARL FELDBAUM - BIOTECHNOLOGY INDUSTRY ORGANIZATION.
ANALYST INTERVIEW: BIOTECHNOLOGY PATENT LAW: AN OVERVIEW: KEVIN NOONAN - MCDONNELL BOEHNEN HULBERT & BERGHOFF.
ANALYST INTERVIEW: BIOTECHNOLOGY & VENTURE CAPITAL: CARL GORDON - ORBIMED ADVISORS LLC.
ANALYST INTERVIEW: REPORTING ON BIOTECHNOLOGY: JUSTIN GILLIS - THE WASHINGTON POST.
ANALYST INTERVIEW: BIOTECHNOLOGY STOCKS: ERIC SCHMIDT - SG COWEN SECURITIES CORPORATION.
ANALYST INTERVIEW: EMERGING BIOTECHNOLOGY COMPANIES:MARK MONANE - NEEDHAM & CO.
ANALYST INTERVIEW: RAIL INDUSTRY OVERVIEW: THOMAS WADEWITZ - BEAR, STEARNS & CO.
Welcome to the third supplement of YIELD, where we cover the business of food, fiber and agriculture.
ANALYST INTERVIEW: SMALL CAP BIOTECHNOLOGY STOCKS: MARK KARVOSKY - PIPER JAFFRAY & CO.
Science and civilisation in China; v.5: Chemistry and chemical technology; pt.11: Ferrous metallurgy.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles